Cargando…
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy
BACKGROUND: An elevation in iron levels, together with an accumulation of α-synuclein within the oligodendrocytes, are features of the rare atypical parkinsonian disorder, Multiple System Atrophy (MSA). We have previously tested the novel compound ATH434 (formally called PBT434) in preclinical model...
Autores principales: | Finkelstein, David I., Shukla, Jay J., Cherny, Robert A., Billings, Jessica L., Saleh, Eiman, Stefanova, Nadia, Barnham, Kevin J., Adlard, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028676/ https://www.ncbi.nlm.nih.gov/pubmed/34744051 http://dx.doi.org/10.3233/JPD-212877 |
Ejemplares similares
-
ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
por: Beauchamp, Leah C., et al.
Publicado: (2022) -
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
por: Diwakarla, Shanti, et al.
Publicado: (2021) -
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
por: Finkelstein, David I., et al.
Publicado: (2017) -
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
por: Finkelstein, David I., et al.
Publicado: (2021) -
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
por: Dening, Yanina, et al.
Publicado: (2022)